These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11007778)

  • 1. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
    Hoang TT; Schweizer HP
    J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
    Heath RJ; Li J; Roland GE; Rock CO
    J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
    Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
    J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
    Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
    J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
    Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
    Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.
    Kim KH; Park JK; Ha BH; Moon JH; Kim EE
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):246-8. PubMed ID: 17329825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance.
    Zhu L; Bi H; Ma J; Hu Z; Zhang W; Cronan JE; Wang H
    mBio; 2013 Oct; 4(5):e00613-13. PubMed ID: 24085780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
    Lee IH; Kim EJ; Cho YH; Lee JK
    Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
    Zhu L; Lin J; Ma J; Cronan JE; Wang H
    Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
    Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
    Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
    Lu H; Tonge PJ
    Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
    Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
    Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
    Lee JH; Park AK; Chi YM; Moon JH; Lee KS
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
    Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
    J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.